Avid Bioservices Inc (CDMO)

[entdoc]

Tidbits gathered at Stanford homecoming this weekend in random conversations: met Thorpe's best friend. He is going to introduce me to Brekken. He thinks it is "going to happen" but is not invested due to conflict of interest, faculty at UTSW, etc. Thinks Thorpe's problem was a myocardial infarction, and almost certainly due to an unsuspected hyperlipidemic situation. Talked with the former Columbia U, and now UCLA "inventor" of the monoclonal AB synthesis recipe who is working on an exciting new treatment with Immugen (not Immunogen). She has not heard of Peregrine, Bavituximab, or anti-PS, and has been in the MAB business for 40 years. The latter is not necessarily a bad thing. The former is not necessarily a good thing. This report is merely an attempt at perspective. The take away: those close to the subject and who know the principals and principles are upbeat, and there are at least some intimately familiar with the field who are not yet familiar with Bavi. That is a lot better than the inventor of the MAB being down on it. She seemed interested. You see, no one person can know it all. So we have some more work to do in that area. More to follow. I still think "it" is going to happen.